Advertisement
Advertisement

COCH

COCH logo

Envoy Medical, Inc. Class A Common Stock

0.66
USD
Sponsored
0.00
+0.26%
Jul 24, 15:59 UTC -4
Closed
exchange

After-Market

0.67

0.00
+0.35%

COCH Earnings Reports

Positive Surprise Ratio

COCH beat 2 of 9 last estimates.

22%

Next Report

Date of Next Report
Aug 17, 2026
Estimate for Q2 26 (Revenue/ EPS)
$61.20K
/
-$0.09
Implied change from Q1 26 (Revenue/ EPS)
+56.92%
/
+80.00%
Implied change from Q2 25 (Revenue/ EPS)
-21.54%
/
-71.88%

Envoy Medical, Inc. Class A Common Stock earnings per share and revenue

On May 11, 2026, COCH reported earnings of -0.05 USD per share (EPS) for Q1 26, beating the estimate of -0.14 USD, resulting in a 64.99% surprise. Revenue reached 39.00 thousand, compared to an expected 61.20 thousand, with a -36.27% difference. The market reacted with a -0.23% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 61.20 thousand USD, implying an increase of 80.00% EPS, and increase of 56.92% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
Jul 14, 2026 For Q4 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+23.75%
logo
Thermo Fisher Scientific, Inc.
Report Date
Jul 23, 2026 For Q2 26
Estimate
$5.76
Actual
$6.03
Surprise
+4.53%
logo
Intuitive Surgical Inc.
Report Date
Jul 16, 2026 For Q2 26
Estimate
$2.55
Actual
$2.80
Surprise
+9.79%
logo
Edwards Lifesciences Corp
Report Date
Jul 23, 2026 For Q2 26
Estimate
$0.76
Actual
$0.78
Surprise
+2.27%
FAQ
For Q1 2026, Envoy Medical, Inc. Class A Common Stock reported EPS of -$0.05, beating estimates by 64.99%, and revenue of $39.00K, -36.27% below expectations.
The stock price moved down -0.23%, changed from $0.65 before the earnings release to $0.64 the day after.
The next earning report is scheduled for Aug 17, 2026.
Based on 3 analysts, Envoy Medical, Inc. Class A Common Stock is expected to report EPS of -$0.09 and revenue of $61.20K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement